Activity of penciclovir against Epstein-Barr virus

Antimicrob Agents Chemother. 1995 Jul;39(7):1599-602. doi: 10.1128/AAC.39.7.1599.

Abstract

Penciclovir inhibited the productive replication cycle of Epstein-Barr virus (EBV) in assays measuring infectious virus production, viral antigen expression, and viral DNA synthesis. In the test measuring inhibition of EBV DNA synthesis, 50% effective concentrations of penciclovir and acyclovir were 2.3 +/- 0.8 and 2.2 +/- 0.6 micrograms/ml, respectively. The 50% cell growth inhibitory concentration of penciclovir was > 100 micrograms/ml for both P3HR-1 and Raji cells. Penciclovir is a selective inhibitor of EBV in cell culture.

MeSH terms

  • Acyclovir / analogs & derivatives*
  • Acyclovir / pharmacology
  • Acyclovir / toxicity
  • Antigens, Viral / analysis
  • Antiviral Agents / pharmacology*
  • Antiviral Agents / toxicity
  • B-Lymphocytes / virology
  • Cells, Cultured
  • DNA, Viral / drug effects
  • Enzyme-Linked Immunosorbent Assay
  • Guanine
  • Herpesvirus 4, Human / drug effects*
  • Herpesvirus 4, Human / physiology
  • Humans
  • Virus Replication / drug effects

Substances

  • Antigens, Viral
  • Antiviral Agents
  • DNA, Viral
  • penciclovir
  • Guanine
  • Acyclovir